InChI=1S/C22H34O5/c1- 2- 19(23) 13- 7- 3- 4- 8- 14- 20(24) 15- 9- 5- 10- 16- 21(25) 17- 11- 6- 12- 18- 22(26) 27/h3- 5,7- 10,13- 14,16,19- 21,23- 25H,2,6,11- 12,15,17- 18H2,1H3,(H,26,27) /b4- 3- ,9- 5- ,13- 7+,14- 8+,16- 10+ |
GGPSRSCVYRYOSY-PJPPRHTRSA-N |
CCC(\C=C\C=C/C=C/C(C\C=C/C=C/C(CCCCCC(=O)O)O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(8E,10Z,14E,16Z,18E)- 7,13,20- trihydroxydocosa- 8,10,14,16,18- pentaenoic acid
|
(8E,10Z,14E,16Z,18E)-7,13,20-trihydroxydocosapentaenoic acid
|
ChEBI
|
RvT1
|
ChEBI
|
26236990
|
PubMed citation
|
Europe PMC
|
27704804
|
PubMed citation
|
Europe PMC
|
|